insights_auto
Why is EDIT down 8.87%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.67
arrow_downward
-8.87%(-0.26) 1D
$2.70
arrow_upward
+1.12% (+0.030)bedtimeAfter hours
Closed: Oct 30, 3:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.89
High
$2.92
Low
$2.60
Mkt. cap
410.06M
Avg. vol.
2.97M
Volume
2.91M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.89
High
$2.92
Low
$2.60
Mkt. cap
410.06M
Avg. vol.
2.97M
Volume
2.91M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
아시아경제
·
18 minutes ago
'ACE U.S. Dividend Dow Jones' ETF Surpasses KRW 1 Trillion in Net Assets
Traders Union
·
1 hour ago
Michael A. Gayed: Weekly signal did not capture five-day panic in March 2023
The Economic Times
·
1 hour ago
US Stock Market prediction: S&P 500, Nasdaq, Dow Jones, Russell 2000 set for surprise opening on Monday, A
BigGo Finance
·
13 hours ago
Nasdaq's 5.3% October Swoon: AI Capex Fears Meet a History of 24% Rebound Years
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc